Research progress in Guanxin Tongluo capsule for the treatment of coronary heart disease
10.3760/cma.issn1008-6706.2022.01.035
- VernacularTitle:冠心通络胶囊治疗冠心病研究进展
- Author:
Guoqian WANG
1
;
Jinkang ZHANG
;
Zhengke YU
;
Zhihong CHEN
;
Hongtu XIE
Author Information
1. 中山大学孙逸仙纪念医院心血管内科，广州 510120
- Keywords:
Coronary disease;
Angina pectoris;
Guanxin tongluo capsule;
Medicine,chinese traditional;
Plant preparations;
Pharmacology,clinical;
Clinical study;
Review
- From:
Chinese Journal of Primary Medicine and Pharmacy
2022;29(1):157-160
- CountryChina
- Language:Chinese
-
Abstract:
Guanxin Tongluo capsule is a compound traditional Chinese medicine preparation for the treatment of coronary heart disease. The underlying mechanism may be related to expanding coronary artery, increasing coronary artery blood flow, reducing myocardial oxygen consumption, and decreasing whole blood viscosity, plasma viscosity, and hematocrit. This paper reviews the clinical research progress of Guanxin Tongluo capsule in the treatment of coronary heart disease from the aspects of etiology, pathogenesis, pharmacological research, and clinical research, providing evidence for scientific research and clinical application of Guanxin Tongluo capsule.
